Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2023 Concepts
- Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) To Accelerate Diagnostic and Vaccine Development
- Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease
- Partnerships for the Development of Vaccines Against Select Bacterial Enteric Pathogens
- Partnerships for the Development of Novel Therapeutics To Combat Select Antibiotic-Resistant Bacteria and Fungi
- Development and Optimization of Next-Generation Immunological Assays To Support Influenza Clinical Studies and Trials
- Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery
- Notice of Special Interest (NOSI)—Advancing Research Needed To Develop a Universal Influenza Vaccine
FY 2023 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Adaptation of CRISPR-Based In Vitro Diagnostics for Rapid Detection of Select Eukaryotic Pathogens
- Artificial Intelligence To Improve Clinical Microscopy for Diagnosis of Infectious Diseases
- Modular Sample Preparation for In-Field Viral Discovery
- Advanced and Immersive Visualization Tools for Infectious and Immune-Mediated Disease Research
- Data Science Tools for Infectious and Immune-Mediated Disease Research
Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) To Accelerate Diagnostic and Vaccine Development
For the published request for applications, check the May 13, 2022 Guide announcement, Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) To Accelerate Diagnostic and Vaccine Development (R01, Clinical Trial Not Allowed).
Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease
For the published request for applications, see the July 20, 2022 Guide announcement, Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed) .
Partnerships for the Development of Vaccines Against Select Bacterial Enteric Pathogens
For the published request for applications, check the May 10, 2022 Guide announcement, Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01, Clinical Trial Not Allowed).
Partnerships for the Development of Novel Therapeutics To Combat Select Antibiotic-Resistant Bacteria and Fungi
For the published request for applications, check the April 5, 2022 Guide announcement, Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed).
Development and Optimization of Next-Generation Immunological Assays To Support Influenza Clinical Studies and Trials
For the published request for applications, check the April 5, 2022 Guide announcement, Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed).
Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery
For the published notice of special interest, check the December 2, 2021 Guide notice, Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery.
Notice of Special Interest (NOSI)—Advancing Research Needed To Develop a Universal Influenza Vaccine
For the published notice of special interest, check the December 13, 2021 Guide notice, Notice of Special Interest (NOSI)—Advancing Research Needed To Develop a Universal Influenza Vaccine.
Adaptation of CRISPR-Based In Vitro Diagnostics for Rapid Detection of Select Eukaryotic Pathogens
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Artificial Intelligence To Improve Clinical Microscopy for Diagnosis of Infectious Diseases
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Modular Sample Preparation for In-Field Viral Discovery
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Advanced and Immersive Visualization Tools for Infectious and Immune-Mediated Disease Research
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Data Science Tools for Infectious and Immune-Mediated Disease Research
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.